Wattana Karnpaet Public Stock Fundamentals
| NEW Stock | THB 70.00 0.00 0.00% |
Wattana Karnpaet Public fundamentals help investors to digest information that contributes to Wattana Karnpaet's financial success or failures. It also enables traders to predict the movement of Wattana Stock. The fundamental analysis module provides a way to measure Wattana Karnpaet's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Wattana Karnpaet stock.
Wattana |
Wattana Karnpaet Public Company Return On Equity Analysis
Wattana Karnpaet's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Wattana Karnpaet Return On Equity | 0.23 |
Most of Wattana Karnpaet's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Wattana Karnpaet Public is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Wattana Karnpaet Public has a Return On Equity of 0.226. This is 100.94% lower than that of the Health Care Providers & Services sector and 115.92% lower than that of the Health Care industry. The return on equity for all Thailand stocks is 172.9% lower than that of the firm.
Wattana Karnpaet Public Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Wattana Karnpaet's current stock value. Our valuation model uses many indicators to compare Wattana Karnpaet value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Wattana Karnpaet competition to find correlations between indicators driving Wattana Karnpaet's intrinsic value. More Info.Wattana Karnpaet Public is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Wattana Karnpaet Public is roughly 1.76 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Wattana Karnpaet's earnings, one of the primary drivers of an investment's value.Wattana Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Wattana Karnpaet's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Wattana Karnpaet could also be used in its relative valuation, which is a method of valuing Wattana Karnpaet by comparing valuation metrics of similar companies.Wattana Karnpaet is currently under evaluation in return on equity category among its peers.
Wattana Fundamentals
| Return On Equity | 0.23 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 1.08 B | |||
| Shares Outstanding | 10 M | |||
| Shares Owned By Insiders | 91.10 % | |||
| Price To Earning | 33.04 X | |||
| Price To Book | 2.56 X | |||
| Price To Sales | 2.25 X | |||
| Revenue | 327.65 M | |||
| Gross Profit | 76.26 M | |||
| EBITDA | 45.96 M | |||
| Net Income | 8.75 M | |||
| Cash And Equivalents | 27.01 M | |||
| Cash Per Share | 2.70 X | |||
| Total Debt | 19.32 M | |||
| Debt To Equity | 17.60 % | |||
| Current Ratio | 0.90 X | |||
| Book Value Per Share | 44.92 X | |||
| Cash Flow From Operations | 36.62 M | |||
| Earnings Per Share | 9.16 X | |||
| Number Of Employees | 21 | |||
| Beta | 0.34 | |||
| Market Capitalization | 810 M | |||
| Total Asset | 524.95 M | |||
| Retained Earnings | 159 M | |||
| Working Capital | 4 M | |||
| Current Asset | 78 M | |||
| Current Liabilities | 74 M | |||
| Z Score | 24.6 | |||
| Annual Yield | 0 % | |||
| Five Year Return | 0.82 % | |||
| Net Asset | 524.95 M | |||
| Last Dividend Paid | 0.35 |
About Wattana Karnpaet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Wattana Karnpaet Public's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Wattana Karnpaet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Wattana Karnpaet Public based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Wattana Karnpaet Public Company Limited engages in hospital and medical trading businesses in Thailand. The company was founded in 1985 and is based in Udon Thani, Thailand. Wattana Karnpaet operates under Medical Care classification in Thailand and is traded on Stock Exchange of Thailand.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Wattana Stock
Wattana Karnpaet financial ratios help investors to determine whether Wattana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wattana with respect to the benefits of owning Wattana Karnpaet security.